1 We performed a randomized,
active control trial to assess the
2 METHODS AND
We performed a randomized (
at patient level, blocks of 4), co
3 compared with the effect of oral vitamin D3 supplementation.
We performed a randomized clinical trial in vitamin D-deficie
4 We performed a randomized controlled trail to investigate the
5 We performed a randomized controlled trial (RCT) to investiga
6 We performed a randomized controlled trial in the same popula
7 We performed a randomized controlled trial of 2245 employees
8 We performed a randomized controlled trial of blended learnin
9 We performed a randomized controlled trial of monovalent oral
10 We performed a randomized controlled trial of patients underg
11 We performed a randomized controlled trial to determine the e
12 We performed a randomized controlled trial to determine wheth
13 We performed a randomized controlled trial to determine wheth
14 We performed a randomized controlled trial to determine wheth
15 We performed a randomized controlled trial to study the effec
16 We performed a randomized controlled trial.
17 We performed a randomized,
controlled phase 2 trial to assess
18 We performed a randomized crossover-controlled exposure study
19 We performed a randomized,
crossover, double-blind, placebo-c
20 To reduce the incidence of IART after the Fontan procedure,
we performed a randomized,
double-blind study to evaluate the
21 We performed a randomized,
double-blind, parallel-group, forc
22 We performed a randomized,
double-blind, phase 2b study to as
23 We performed a randomized,
double-blind, placebo-controlled c
24 We performed a randomized,
double-blind, placebo-controlled s
25 We performed a randomized,
double-blind, placebo-controlled t
26 hort pilot phase (40 mg lovastatin vs placebo in 30 cases),
we performed a randomized,
double-blind, placebo-controlled t
27 We performed a randomized,
double-blind, placebo-controlled t
28 We performed a randomized,
double-blind, placebo-controlled t
29 We performed a randomized,
double-blind, placebo-controlled t
30 We performed a randomized,
double-blind, placebo-controlled t
31 We performed a randomized,
double-blind, placebo-controlled t
32 We performed a randomized,
double-masked, placebo-controlled
33 We performed a randomized,
international, double-blind, phase
34 We performed a randomized noninferiority trial in 17 Dutch ho
35 We performed a randomized,
open-label, equivalence trial amon
36 We performed a randomized,
parallel, investigator-blind contr
37 We performed a randomized,
parallel, single-blind dose-rangin
38 We performed a randomized Phase I/II, observer-blind, placebo
39 We performed a randomized phase III trial assessing dose inte
40 We performed a randomized,
phase 2 study to compare the effec
41 We performed a randomized placebo-controlled trial to determi
42 We performed a randomized,
placebo-controlled crossover study
43 We performed a randomized,
placebo-controlled study to determ
44 We performed a randomized,
placebo-controlled study using C1-
45 We performed a randomized,
placebo-controlled, double-blind t
46 We performed a randomized pragmatic trial from September 7, 2
47 We performed a randomized trial of the ability of the neuroki
48 We performed a randomized trial to compare the ability of inf
49 Methods
We performed a randomized trial to evaluate treatment adaptat
50 We performed a randomized trial with magnetic resonance imagi